Ig Glycosylation in Ulcerative Colitis: It's Time for New Biomarkers
Background: Ulcerative colitis (UC) is a chronic relapsing disease, which needs a continue monitoring, especially during biological therapies. An increasing number of patients is treated with anti-Tumor Necrosis factor (TNF) drugs, and current research is focalized to identify biomarkers able to mon...
Saved in:
Main Authors: | Riccardo Capecchi (Author), Paola Migliorini (Author), Federico Zanzi (Author), Simona Maltinti (Author), Ilaria Puxeddu (Author), Nicola de Bortoli (Author), Massimo Bellini (Author), Francesco Costa (Author), Santino Marchi (Author), Lorenzo Bertani (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CXCL12/SDF-1 in IgG4-Related Disease
by: Riccardo Capecchi, et al.
Published: (2021) -
Association of ulcerative colitis and IgA nephropathy: A case report
by: S Boulajaad, et al.
Published: (2021) -
Impact of Glycosylation on Effector Functions of Therapeutic IgG
by: Jean-Luc Teillaud, et al.
Published: (2010) -
Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?
by: Ilaria Puxeddu, et al.
Published: (2017) -
Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients
by: Petr Kosztyu, et al.
Published: (2018)